FORM vs IBM
Side-by-side quantum stock comparison: market cap, share price, classification, and thesis.
Market cap, head to head
Stat-by-stat
| Metric | FORM | IBM |
|---|---|---|
| Type | Diversified | Diversified |
| Segment | Hardware | Hardware + Software |
| Exchange | NASDAQ | NYSE |
| Country | US | US |
| Market cap | $10.64B | $235.62B |
| Share price | $136.48 | $250.69 |
| Employees | 2,238 | 270,300 |
| Sector | Technology | Technology |
| Industry | Semiconductors | Information Technology Services |
Quantum thesis
FormFactor sells cryogenic probe stations and test equipment used to characterize superconducting and spin qubit chips. It is a classic picks-and-shovels exposure: every quantum hardware lab buying cryogenic test infrastructure is a potential customer, but quantum is only a fraction of a broader semiconductor-test revenue base.
Full FORM page →Quantum thesis
IBM runs the most mature commercial quantum program of any public company. IBM Quantum operates a fleet of superconducting processors over the cloud, publishes a detailed hardware roadmap, and ships Qiskit, the most widely used open-source quantum software stack. Quantum is a tiny share of IBM revenue, but no other diversified bet has more direct quantum exposure or a longer track record.
Full IBM page →